Detalles de la búsqueda
1.
Efficacy and safety of insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi) in Japanese patients with type 2 diabetes mellitus inadequately controlled on basal insulin and oral antidiabetic drugs: The LixiLan JP-L randomized clinical trial.
Diabetes Obes Metab
; 22 Suppl 4: 3-13, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32072742
2.
Efficacy and Safety of 1:1 Fixed-Ratio Combination of Insulin Glargine and Lixisenatide Versus Lixisenatide in Japanese Patients With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs: The LixiLan JP-O1 Randomized Clinical Trial.
Diabetes Care
; 43(6): 1249-1257, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32295808
3.
Safety, tolerability and efficacy of lixisenatide in combination with oral antidiabetic treatment in Japanese patients with type 2 diabetes: An open-label, multicenter study.
J Diabetes Investig
; 9(1): 127-136, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28429860
4.
Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial.
Diabetes Care
; 39(11): 1972-1980, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27650977
5.
Long-term safety of once-daily lixisenatide in Japanese patients with type 2 diabetes mellitus: GetGoal-Mono-Japan.
J Diabetes Complications
; 29(8): 1304-9, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26342556
6.
Erratum. Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial. Diabetes Care 2016;39:1972-1980.
Diabetes Care
; 40(6): 809, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28428368
Resultados
1 -
6
de 6
1
Próxima >
>>